Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of October 29, 2026, PDEX trades at $62.89 with a market cap of $201.33M and a P/E ratio of 14.77. PDEX moved +0.00% today. Year to date, PDEX is +67.52%; over the trailing twelve months it is +120.10%. Its 52-week range spans $23.47 to $77.00. Analyst consensus is buy with an average price target of $74.00. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pro-Dex Inc New (PDEX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PDEX moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $62.89 |
| Market Cap | $201.33M |
| P/E Ratio | 14.77 |
| EPS | $4.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $77.00 |
| 52-Week Low | $23.47 |
| Volume | 30.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $77.55M |
| Net Income | $13.66M |
| Gross Margin | 31.38% |
1 analysts cover PDEX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $74.00.